Rankings
▼
Calendar
VTYX FY 2019 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
VTYX
Ventyx Biosciences, Inc.
$1B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-2.29
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$198,000
Balance Sheet
Total Assets
$349,000
Total Liabilities
$4M
Stockholders' Equity
-$4M
Cash & Equivalents
$309,000
← Q1 2020
All Quarters